slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,091-3,120
Pages 202
Rows per page 30
Slide function
3,091-3,120 of 6,044
14
The slide uses a timeline-based layout to map clinical development stages (Late Stage vs Proof-of-Concept) against expected data readout years (2023, 2024, 2025+).argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Cost Of Inaction1 hit
17
The slide uses a process diagram to show the progression from healthy volunteer studies to patient trials.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
20
The slide uses a timeline-like structure to map specific drug development and commercialization events to their expected quarters in 2023.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
22
The chart uses a horizontal bar format to represent clinical development stages (Preclinical to Commercial) for multiple indications under three main programs (VYVGART, ARGX-117, ARGX-119).argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide combines a historical achievement list with a forward-looking roadmap and financial runway statement.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
25
The slide outlines a 22-24 week process involving SCR and the SIRE Conflicts Committee.Bank of America | Investment Banking Pitch Book | 30 slides · BofA Securities
Consulting deck Investment bank 1 hit
26
The slide contrasts two distinct legal pathways for taking an MLP private, highlighting the difference in duration and process steps.Bank of America | Investment Banking Pitch Book | 30 slides · BofA Securities
Consulting deck Investment bank 1 hit
03
The slide uses a circular process flow with checkmarks indicating completed or ongoing strategic actions.Bridge Investment Group | SPAC Presentation Deck | 16 slides · Bridge Investment Group
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
83
Canada Goose | Investor Day Presentation Deck | 161 slidesCanada Goose | Investor Day Presentation Deck | 161 slides · Canada Goose
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
93
The slide uses a background image of a retail display with four circular callouts overlaying the key strategic pillars.Canada Goose | Investor Day Presentation Deck | 161 slides · Canada Goose
Conference presentation Investor relations Beat · Action1 hit
04
The chart uses a horizontal bar format to represent the development stage of various drug candidates.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
24
The slide outlines a 2:1 randomized clinical trial structure for a drug combination (CTX-009 + Paclitaxel) versus a control (Paclitaxel).Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
The slide uses a three-column layout to represent sequential or parallel development tracks.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
32
Compass Therapeutics | Investor Presentation Deck | 40 slidesCompass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
37
The slide outlines the current progress and future clinical trial design for a drug candidate.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
40
The timeline uses blue and red color coding for different drug programs or status types.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Includes a timeline at the bottom and two bar charts showing RWA and leverage exposure reduction.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
The slide uses a horizontal arrow-based timeline to represent strategic phases.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
33
The slide uses a three-column layout to define strategic financial goals.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Financials1 hit
08
The slide uses a Gantt-chart style visualization to show the progress of multiple drug candidates across clinical phases.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
10
The slide uses a structured layout to compare three distinct product pipelines.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
11
The slide uses a two-tier layout to distinguish between Phase 1 and Preclinical development stages.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
15
The slide uses a simple list format to communicate upcoming program milestones.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
72
The slide uses a process diagram to illustrate the drug discovery pipeline integrated with various omics and predictive technologies.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
104
The slide uses a process flow diagram to illustrate the clinical trial stages for Cohort A (Phase 2) and Cohort B (Phase 3).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
08
The slide uses a column-based layout to present a strategic playbook.Snap Inc | Investor Presentation Deck | 52 slides · Snap Inc.
Pitch deck Investor relations Beat · Problem1 hit
46
Uses a three-pillar framework to explain financial strategy.Snap Inc | Investor Presentation Deck | 52 slides · Snap Inc.
Pitch deck Investor relations Beat · Team1 hit
47
The slide uses a three-column layout to categorize strategic priorities, with a footer emphasizing financial outcomes (EBITDA/FCF).Snap Inc | Investor Presentation Deck | 52 slides · Snap Inc.
Pitch deck Investor relations Beat · Team1 hit